Allocating a One-Time Opioid Settlement in a Rural County
A rural county with 48,000 residents recorded 38 overdose deaths last year, up from 19 three years earlier. Autopsy toxicology attributes 62% to illicitly manufactured fentanyl, often pressed into counterfeit oxycodone tablets. The county has one hospital, two pharmacies, and a syringe services program operating from a mobile van two afternoons a week. Only two physicians hold a DEA waiver to prescribe buprenorphine, and the nearest opioid treatment program is 70 miles away. The sheriff publicly opposes expanding syringe services, arguing it 'enables drug use,' while the school district reports rising suspensions for vaping-related drug use. The county receives a one-time $200,000 opioid settlement payment and must choose among: naloxone bulk purchase and community distribution; expanding syringe services hours; telehealth buprenorphine initiation; or a media campaign. Baseline naloxone distribution is 120 kits per year; estimated need is 600.
1. How should the county prioritize the $200,000, and what evidence supports your ranking?
Read the worked answer
The first priority should be naloxone saturation because it addresses immediate mortality and the county is far below estimated need. A bulk purchase and community distribution plan that includes people who use drugs, their families, and first responders can plausibly close much of the 480-kit gap. The second priority is low-barrier buprenorphine access, because medication for opioid use disorder reduces overdose death and retention is improved when initiation is easy. Expanding syringe services hours is also evidence-based for HIV and hepatitis C prevention and can serve as a gateway to treatment.
A media campaign alone is the weakest option for a one-time payment; it may reduce stigma but does not directly reverse overdoses. A defensible split would fund naloxone first, then buprenorphine initiation and syringe services, with a small evaluation budget. The ranking should be explicit: interventions that prevent death now outrank those with delayed or indirect effects.
2. The sheriff opposes syringe services. What public health and legal arguments, and what operational compromises, could address the impasse?
Read the worked answer
The public health argument is that syringe services reduce needle sharing and HIV and hepatitis C transmission without increasing crime or injection frequency in most studies. They also provide a setting for naloxone distribution, wound care, and referral to treatment. The legal argument depends on state law: many states authorize syringe services and provide protections for participants and staff. Clarify what is permitted locally rather than debating the principle in the abstract.
Operationally, invite the sheriff to a community advisory board, share data on needles recovered versus distributed, and locate the van where it reduces public disorder complaints. Offer law enforcement training on occupational needle-stick prevention and post-exposure prophylaxis. A compromise that pairs expansion with a one-for-one return policy or a fixed-site kiosk may be more acceptable than an open-ended program, but do not sacrifice the core benefit of easy access.
3. What indicators should be monitored to judge success after 12 months?
Read the worked answer
Track fatal and nonfatal overdoses, naloxone kits distributed and reported reversals, and the percentage of kits that reach people at highest risk. For buprenorphine, measure the number of new initiations, 30-day retention, and whether prescribers accept uninsured patients. For syringe services, measure encounters, syringes distributed and returned, HIV and hepatitis C tests, and referrals to treatment. Also track jail bookings for syringe possession if state law permits.
Process measures such as media reach are secondary. A dashboard should be public and reviewed quarterly. If overdoses fall but naloxone distribution remains low, the conclusion may be that the intervention was not implemented at scale rather than that it failed.